Highlights
- Joint investment to capture sizeable market opportunities and significantly increase Abu Dhabi’s capacity to deliver comprehensive veterinary healthcare and vaccinations
- State-of-the-art equine and camel hospitals will be developed in Abu Dhabi
- A new facility for advanced animal vaccine treatments is planned to serve the Middle East and Africa
ADQ, an Abu Dhabi-based investment and holding company, and E20 Investment, an agribusiness investment company in the UAE, today entered into an agreement to establish a new animal health platform in Abu Dhabi, representing a landmark milestone for the region’s animal healthcare industry.
The animal health platform will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals. Once operational, the facilities will further enhance Abu Dhabi’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.
About ADQ
Established in 2018, ADQ is an active global sovereign investor with a focus on critical infrastructure and supply chains. As a strategic partner to the Government of Abu Dhabi, ADQ invests in the growth of business platforms anchored in the Emirate that deliver value to local communities and long-term financial returns to its shareholder. ADQ’s expanding portfolio has a total book value of USD 225 billion (as at 30 June 2024) and encompasses companies across numerous core sectors of the economy, including energy and utilities, transport and logistics, food and agriculture, and healthcare and life sciences.
For more information, visit adq.ae or write to media@adq.ae. You can also follow ADQ on Instagram, LinkedIn, and X.
Direct to your inbox
ADQ News and Insights delivered directly to your inbox